Next Article in Journal
Pulmonary Oxalosis in Pulmonary Aspergillosis Syndrome
Previous Article in Journal
Acute Eosinophilic Pneumonia Associated with Non-Cigarette Smoking Products: A Systematic Review
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Volume-Assured Pressure Support Mode Plus Pirfenidone as Resuscitation Therapy in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis

by
Killen Harold Briones Claudett
1,2,3,*,
Mónica H. Briones Claudett
2,3,
Estupiñan Vargas Domenica
1,2,
Stalin Rodriguez Garcia
1,2,
Cesar Andrade Cabrera
3,
Jaime Benites Solis
4 and
Michelle Grunauer Andrade
5
1
Universidad de Guayaquil, Facultad de Ciencias Médicas, Guayaquil, Ecuador
2
Centro Fisiológico-Respiratorio Briones-Claudett, Guayaquil, Ecuador
3
Intensive Care Unit, Ecuadorian Institute of Social Security , Babahoyo, Ecuador, Juan Anoleto, Babahoyo, Ecuador
4
OMNIHospital, Abel Castillo R omero y Av. Juan Tanca Marengo, Guayaquil, Ecuador
5
Universidad San Francisco de Quito, Quito, Ecuador
6
School of Medicine, Quito, Ecuador
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2020, 88(2), 147-152; https://doi.org/10.5603/ARM.2020.0077
Submission received: 19 May 2019 / Revised: 16 August 2019 / Accepted: 16 August 2019 / Published: 30 April 2020

Abstract

Introduction: Treatment among advanced stage idiopathic pulmonary fibrosis is quite challenging, especially considering that no major evidence has been released about it. This Case Report demonstrates and discusses the benefit of non-invasive mechanical ventilation in volume-assured pressure support (AVAPS) mode plus pirfenidone based on the relief of apatient’ssymptoms in combination with high-resolution computed tomography (HRCT) evidence. Material and methods: An 83-year-old female patient with multiple hospital admissions within a six-month period initially presented with cardiac symptoms which were later attributed to apossible exacerbation of her primary diagnosis, idiopathic pulmonary fibrosis. Conclusion: The addition of non-invasive mechanical ventilation in AVAPS mode plus pirfenidone can improve the survival rates even in patients with current exacerbations of acute respiratory failure due to idiopathic pulmonary fibrosis.
Keywords: pirfenidone; idiopathic pulmonary fibrosis; non-invasive ventilator pirfenidone; idiopathic pulmonary fibrosis; non-invasive ventilator

Share and Cite

MDPI and ACS Style

Briones Claudett, K.H.; Briones Claudett, M.H.; Domenica, E.V.; Garcia, S.R.; Cabrera, C.A.; Solis, J.B.; Andrade, M.G. Volume-Assured Pressure Support Mode Plus Pirfenidone as Resuscitation Therapy in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis. Adv. Respir. Med. 2020, 88, 147-152. https://doi.org/10.5603/ARM.2020.0077

AMA Style

Briones Claudett KH, Briones Claudett MH, Domenica EV, Garcia SR, Cabrera CA, Solis JB, Andrade MG. Volume-Assured Pressure Support Mode Plus Pirfenidone as Resuscitation Therapy in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis. Advances in Respiratory Medicine. 2020; 88(2):147-152. https://doi.org/10.5603/ARM.2020.0077

Chicago/Turabian Style

Briones Claudett, Killen Harold, Mónica H. Briones Claudett, Estupiñan Vargas Domenica, Stalin Rodriguez Garcia, Cesar Andrade Cabrera, Jaime Benites Solis, and Michelle Grunauer Andrade. 2020. "Volume-Assured Pressure Support Mode Plus Pirfenidone as Resuscitation Therapy in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis" Advances in Respiratory Medicine 88, no. 2: 147-152. https://doi.org/10.5603/ARM.2020.0077

Article Metrics

Back to TopTop